Exenatide
TAO
AstraZeneca · Phase 3 · Completed · Enrollment 45
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| exenatide | Obesity or overweight | n/r | n/r | n/r | n/r |
Disease Pipeline Tools Obesity
Obesity
Programs, trials, and reported weight change for obesity and overweight.
Exenatide
AstraZeneca · Phase 3 · Completed · Enrollment 45
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |
| exenatide | Obesity or overweight | n/r | n/r | n/r | n/r |